Search

everythinglearnresearchcommunity

for

Search:↓

Postoperative folliculitis after hair transplants is a minor issue that doesn't relate to patient details or how much hair is transplanted.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

CD2 might be a new treatment target for patchy alopecia areata.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Skin aging reflects overall body aging and can indicate internal health conditions.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Upadacitinib may effectively treat alopecia areata without side effects.

Trichoscopy can reliably distinguish between alopecia areata and trichotillomania.

Method B with propylene glycol is better for stable low-concentration DPCP solutions for alopecia areata.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

The skin's bacteria might influence the development of a hair loss condition called alopecia areata.

Calcipotriol may effectively treat hair loss in alopecia areata, working better in children than adults.

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Tofacitinib is effective and safe for treating severe alopecia areata.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

The study suggests that hypothyroidism may cause alopecia areata.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.